Cytokinetics Stock Options

CYTK
 Stock
  

USD 47.25  0.22  0.46%   

Cytokinetics' option chain provides insight into all available option contracts written on Cytokinetics' stock. Investors can see outstanding put and call contracts with pricing information and greeks for a given expiration period. In addition, each of Cytokinetics' stock options below provides a detailed picture of the payoff. Comparing vital and dynamic information of various option contracts across diverse expiration periods will help you make an educated decision on your market timing strategies around investing in a given Cytokinetics option contract. View S&P 500 options
  
Refresh
Purchasing Cytokinetics options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Cytokinetics calls. Remember, the seller must deliver Cytokinetics stock to the call owner when a call is exercised.

In The Money vs. Out of Money Option Contracts on Cytokinetics

Analyzing Cytokinetics' in-the-money options over time can help investors to take a profitable long position in Cytokinetics regardless of its overall volatility. This is especially true when Cytokinetics' options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Cytokinetics' options could be used as guardians of the underlying stock as they move almost dollar for dollar with Cytokinetics' stock while costing only a fraction of its price.
Cytokinetics' latest option contracts expiring on 2022-07-15 are carrying combined implied volatility of 92.76 with a put-to-call open interest ratio of 0.22 over 60 outstanding agreements suggesting investors are buying way more calls than puts on contracts expiring on 2022-07-15. The current put volume is at 12, with calls trading at the volume of 100. This yields a 0.12 put-to-call volume ratio. The Cytokinetics option chain provides detailed quote and price information for the current Cytokinetics option contracts. It shows all of Cytokinetics' listed puts, calls, expiration dates, strike prices, and other pricing information.

Open Interest Against 2022-07-15 Option Contracts

Cytokinetics option prices can potentially be used to forecast stock returns because most option chains provide information not only about the current prices but also about the future conditions in Cytokinetics' lending market. For example, when Cytokinetics' puts are not actively trading or completely missing in the marketplace, investors can use it to internalize expected shorting costs. So if an investor is writing a put option on Cytokinetics, he or she must hedge the risk by shorting Cytokinetics stock over its option's life.
The chart above shows Cytokinetics' distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Cytokinetics' open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Cytokinetics' option, there is no secondary market available for investors to trade.

Cytokinetics Maximum Pain Price across 2022-07-15 Option Contracts

Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of particular securities such as Cytokinetics close to expiration to expire worthless. According to most research, approximately 10% to 15% of all stock options are exercised, while about 35% expire worthlessly, with roughly 50% traded out before the expiration date. So, Max pain occurs when market makers reach a net positive position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthless.
Cytokinetics' stock options are financial instruments that give investors the right to buy or sell shares of Cytokinetics common stock at a specified price for a given time period. Generally speaking, an option to purchase or sell Cytokinetics stock makes it part of the underlying stock when the option's price is tied to the movement of the underlying stock. If Cytokinetics' stock price goes up or down, the stock options follow.
Continue to Trending Equities.
Please note that buying 'in-the-money' options on Cytokinetics lessens the impact of time decay, as they carry both intrinsic and time value. So, even if Cytokinetics' value remains static through the expiration date, the investor can sell to close an 'in-the-money' option to avoid a potential loss. However, in-the-money Cytokinetics contracts are usually more expensive to enter than their out-of-the-money counterparts. So keep in mind that while the payoffs on an in-the-money trade can be high, the investors could ultimately experience a more consequential loss if Cytokinetics Stock moves the wrong way.
The current Net Income Common Stock is estimated to decrease to about (221 M)

Cytokinetics In The Money Call Balance

When Cytokinetics' strike price is surpassing the current stock price, the option contract against Cytokinetics stock is said to be in the money. When it comes to buying Cytokinetics' options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' options written on Cytokinetics are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.

Cytokinetics Current Options Market Mood

Cytokinetics' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Cytokinetics Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.

Put-to-Call Open Interest

Put-to-Call Volume

Most options investors, including buyers and sellers of Cytokinetics' calls and puts, are not very successful. It is estimated that an average options trader loses somewhere between 80% to 90% of the time. Cytokinetics' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction. Using current Cytokinetics' option volume and open interest to make an investment decision is considered a contrarian-sentiment measure that can be utilized in many timing strategies in both derivative and spot marketplace.

Rule 16 of the current Cytokinetics contract

Base on the Rule 16, the options market is currently suggesting that Cytokinetics will have an average daily up or down price movement of about 5.8% per day over the life of the 2022-07-15 option contract. With Cytokinetics trading at $47.25, that is roughly $2.74. If you think that the market is fully incorporating Cytokinetics' daily price movement you should consider buying Cytokinetics options at the current volatility level of 92.76%. But if you have an opposite viewpoint you should avoid it and even consider selling them.

Cytokinetics Option Chain

When Cytokinetics' strike price is surpassing the current stock price, the option contract against Cytokinetics stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
2022-07-152022-08-192022-11-182023-01-202023-02-172024-01-19
Cytokinetics' option chain is a display of a range of information that helps investors for ways to trade options on Cytokinetics. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Cytokinetics. It also shows strike prices and maturity days for a Cytokinetics against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone.
DeltaGammaOpen IntExpirationCurrent SpreadLast Price
Call
2022-07-15 CALL at $20.00.94180.0035182022-07-1525.2 - 28.420.4In
Call
2022-07-15 CALL at $24.00.93490.0049492022-07-1521.0 - 24.216.7In
Call
2022-07-15 CALL at $25.00.92760.005402022-07-1520.0 - 23.30.0In
Call
2022-07-15 CALL at $26.00.92010.00642022-07-1519.0 - 22.414.9In
Call
2022-07-15 CALL at $27.00.91580.006612022-07-1518.0 - 21.414.0In
Call
2022-07-15 CALL at $28.00.92450.00702022-07-1517.0 - 20.10.0In
Call
2022-07-15 CALL at $29.00.91080.007902022-07-1516.3 - 19.30.0In
Call
2022-07-15 CALL at $30.00.90130.008702022-07-1515.0 - 18.416.9In
Call
2022-07-15 CALL at $31.00.87650.009502022-07-1514.0 - 17.90.0In
Call
2022-07-15 CALL at $32.00.90020.010502022-07-1513.1 - 16.20.0In
Call
2022-07-15 CALL at $33.00.87420.011702022-07-1512.3 - 15.60.0In
Call
2022-07-15 CALL at $34.00.87660.01302022-07-1511.4 - 14.40.0In
Call
2022-07-15 CALL at $35.00.86370.0144102022-07-1510.0 - 13.511.85In
Call
2022-07-15 CALL at $36.00.86060.016112022-07-159.2 - 12.45.7In
Call
2022-07-15 CALL at $37.00.97330.009902022-07-159.0 - 11.70.0In
Call
2022-07-15 CALL at $38.00.81920.0196102022-07-157.4 - 10.83.4In
Call
2022-07-15 CALL at $39.00.95310.017482022-07-157.2 - 9.67.5In
Call
2022-07-15 CALL at $40.00.92260.02493822022-07-156.1 - 8.97.5In
Call
2022-07-15 CALL at $41.00.84640.033262022-07-155.7 - 8.13.0In
Call
2022-07-15 CALL at $42.00.84390.040502022-07-154.4 - 7.20.0In
Call
2022-07-15 CALL at $43.00.85610.051212022-07-153.6 - 6.64.63In
Call
2022-07-15 CALL at $44.00.76880.0609112022-07-153.5 - 5.94.0In
Call
2022-07-15 CALL at $45.00.65970.052810292022-07-153.4 - 4.24.0In
Call
2022-07-15 CALL at $46.00.59660.045902022-07-152.85 - 4.04.0In
Call
2022-07-15 CALL at $47.00.54650.0552882022-07-152.4 - 3.53.0In
Call
2022-07-15 CALL at $48.00.49290.0543972022-07-151.85 - 3.72.61Out
Call
2022-07-15 CALL at $49.00.44490.051732022-07-151.5 - 3.62.32Out
Call
2022-07-15 CALL at $50.00.42360.043382022-07-151.2 - 2.72.53Out
Call
2022-07-15 CALL at $55.00.19330.036432022-07-150.1 - 5.00.75Out
Call
2022-07-15 CALL at $60.00.09590.02102022-07-150.0 - 0.50.34Out
 Put
2022-07-15 PUT at $35.0-0.09760.0142222022-07-150.05 - 1.21.2Out
 Put
2022-07-15 PUT at $36.0-0.11850.016202022-07-150.0 - 1.550.0Out
 Put
2022-07-15 PUT at $37.0-0.12690.018342022-07-150.0 - 1.552.0Out
 Put
2022-07-15 PUT at $38.0-0.13420.020922022-07-150.0 - 1.52.4Out
 Put
2022-07-15 PUT at $39.0-0.21620.020402022-07-150.0 - 4.10.0Out
 Put
2022-07-15 PUT at $40.0-0.20730.02523332022-07-150.05 - 2.951.38Out
 Put
2022-07-15 PUT at $41.0-0.20630.030502022-07-150.1 - 2.30.0Out
 Put
2022-07-15 PUT at $42.0-0.27640.027902022-07-150.1 - 4.60.0Out
 Put
2022-07-15 PUT at $43.0-0.29840.03212022-07-150.15 - 4.51.9Out
 Put
2022-07-15 PUT at $44.0-0.33060.03532022-07-150.4 - 4.73.0Out
 Put
2022-07-15 PUT at $45.0-0.34870.048722022-07-150.9 - 3.04.3Out
 Put
2022-07-15 PUT at $46.0-0.40320.046802022-07-150.5 - 4.80.0Out
 Put
2022-07-15 PUT at $47.0-0.45230.050102022-07-151.95 - 4.73.0Out
 Put
2022-07-15 PUT at $48.0-0.49760.047222022-07-152.15 - 5.49.4In
 Put
2022-07-15 PUT at $49.0-0.54650.04802022-07-152.65 - 5.90.0In
 Put
2022-07-15 PUT at $50.0-0.5830.044732022-07-153.4 - 6.65.1In
 Put
2022-07-15 PUT at $55.0-0.75670.034702022-07-157.2 - 10.60.0In
 Put
2022-07-15 PUT at $60.0-0.85870.023402022-07-1511.2 - 15.50.0In

Cytokinetics Net Income Common Stock Over Time

The amount of net income (loss) for the period due to common shareholders. Typically differs from Net Income to the parent entity due to the deduction of Preferred Dividends Income Statement Impact.
 Net Income Common Stock 
Share
      Timeline 

Cytokinetics Net Income Common Stock USD Over Time

Net Income Common Stock in USD; converted by US Dollar Exchange Rate.
 Net Income Common Stock USD 
Share
      Timeline 

Cytokinetics Historical Liabilities

While analyzing the current debt level is an essential aspect of forecasting the current year budgeting needs of Cytokinetics, understanding its historical liability is critical in projecting Cytokinetics' future earnings, especially during periods of low and high inflation and deflation. Many analysts look at the trend in assets and liabilities and evaluate how Cytokinetics uses its financing power over time.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Cytokinetics without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Stock Screener Now

   

Stock Screener

Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
All  Next Launch Module
Continue to Trending Equities. Note that the Cytokinetics information on this page should be used as a complementary analysis to other Cytokinetics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

Complementary Tools for Cytokinetics Stock analysis

When running Cytokinetics price analysis, check to measure Cytokinetics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cytokinetics is operating at the current time. Most of Cytokinetics' value examination focuses on studying past and present price action to predict the probability of Cytokinetics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Cytokinetics' price. Additionally, you may evaluate how the addition of Cytokinetics to your portfolios can decrease your overall portfolio volatility.
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Go
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Go
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Go
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Go
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Go
Transaction History
View history of all your transactions and understand their impact on performance
Go
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Go
Is Cytokinetics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cytokinetics. If investors know Cytokinetics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cytokinetics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
B
Quarterly Revenue Growth YOY
-0.82
Return On Assets
-0.19
Return On Equity
-2.8
The market value of Cytokinetics is measured differently than its book value, which is the value of Cytokinetics that is recorded on the company's balance sheet. Investors also form their own opinion of Cytokinetics' value that differs from its market value or its book value, called intrinsic value, which is Cytokinetics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cytokinetics' market value can be influenced by many factors that don't directly affect Cytokinetics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cytokinetics' value and its price as these two are different measures arrived at by different means. Investors typically determine Cytokinetics value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cytokinetics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.